Pharmafile Logo
Pharmafocus logo
Advanced Search

Humira

Showing 15 posts of 90 posts found.

humira_abbott_

Humira biosimilar proves efficacy in Phase 3 trial

November 30, 2016
Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta

US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …

News
clinical_trial

GSK/J&J release how their drug measures up against Humira

November 18, 2016
Medical Communications, Research and Development GSK, Humira, Janssen, Johnson & Johnson, sirukumab

GlaxoSmithKline and Janssen, part of Johnson & Johnson, released the results of their two Phase III trials exploring treatment options …

News
abbott_humira

Coherus knocked back by AbbVie’s Humira patent protection

November 8, 2016
Manufacturing and Production, Sales and Marketing AbbVie, Coherus, Humira

Coherus Biosciences, a developer of biosimilars, has suffered a blow in their petition for Inter Partes Review (IPR) of one …

News
jj_2johnson_and_johnson

J&J’s IL-23 drug guselkumab outstrips the competition in Phase III trial

October 3, 2016
Research and Development, Sales and Marketing AbbVie, Humira, Johnson & Johnson, guselkumab

Johnson & Johnson’s IL-23 drug guselkumab proved to be more effective at clearing moderate to severe cases of the plaque …

News
abbvie_0

AbbVie and Eisai celebrate approval of new Humira indication

September 28, 2016
Research and Development, Sales and Marketing AbbVie, Eisai, Humira

AbbVie and Eisai have announced the Japanese approval of a new indication for the former’s anti-TNF-α monoclonal antibody formulation Humira …

News
humira_abbott__4

FDA gives the green light to the first Humira biosimilar

September 26, 2016
Sales and Marketing AbbVie, Amgen, Amjevita, FDA, Humira

Amgen’s Amjevita has been given the go ahead for all eligible indications of its reference product, including moderate-to-severe rheumatoid arthritis, …

News
humira_abbott_

AbbVie files lawsuit against Amgen over Humira copy

August 8, 2016
Research and Development, Sales and Marketing AbbVie, Amgen, FDA, Humira, rheumatoid arthritis

Abbvie has filed a patent infringement lawsuit against Amgen over the latter firm’s copy of its Humira (adalimumab) rheumatoid arthritis …

News
samsung

Samsung Bioepis Humira biosimilar gets accepted for EMA review

July 18, 2016
Research and Development, Sales and Marketing EMA, Humira, Samsung Bioepis, application

The European Medicines Agency (EMA) has accepted for review the marketing authorisation application from Samsung Bioepis for their biosimilar version …

News
fda_logo-web

US FDA committee recommends approval for Amgen’s biosimilar of AbbVie’s Humira

July 13, 2016
Research and Development, Sales and Marketing AbbVie, Amgen, Humira, US FDA, biosimilar, drug approval, drug trial, inflammatory diseases, rheumatoid arthritis

One of the world’s bestselling drug may soon have competition in the US markets after the regulators backed a biosimilar …

News
amgen_hq

Amgen’s Humira biosimilar candidate “highly similar” to originator, says FDA

July 8, 2016
Research and Development, Sales and Marketing ABP-501, AbbVie, Amgen, FDA, Humira, abp 501, biosimilar

A report from a meeting of the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee has concluded that Amgen’s …

News
humira_abbott_

New Humira data shows improved quality of life in ulcerative colitis patients

June 23, 2016
Research and Development AbbVie, Humira, data, ulcerative colitis

New data on Humira (adalimumab) has been presented at the British Society of Gastroenterology, demonstrating the drug’s efficacy and improvement …

News

Nice backs two cancer drugs from Novartis

June 22, 2016
Research and Development, Sales and Marketing AbbVie, Amgen, Humira, NICE, Novartis, Sanofi, lung cancer, skin cancer

The National Institute for Health and Care Excellence (Nice) has backed two drugs form Novartis (VTX: NOVN) for lung cancer …

News
amgen_flag

FDA to review data on Amgen’s Humira biosimilar

June 14, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Amgen, FDA, Humira, biosimilar

Amgen (NASDAQ: AMGN) has announced the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee will review data supporting the …

News
humira_abbott__4

EU ombudsman calls for more transparency from AbbVie on Humira

June 10, 2016
Medical Communications, Research and Development AbbVie, EMA, EU, Humira, ombudsman

Abbvie continues to withhold details of clinical trials involving the world’s top-selling prescription medicine, Humira (adalimumab), according to the European …

News
samsung

New data on biosimilars of the big three anti-TNF drugs presented at EULAR 2016

June 8, 2016
Research and Development, Sales and Marketing Benepali, Biogen, Enbrel, Flixabi, Humira, Remicade, Samsung Bioepis, biosimilars, eular 2016, sb5

Samsung Bioepis has presented data at EULAR 2016 on three biosimilars of the highly selling anti-TNF drugs Remicade (infliximab), Enbrel …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026